Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
104,986,330
-
Total 13F shares
-
93,286,684
-
Share change
-
-152,769
-
Total reported value
-
$66,492,644,189
-
Put/Call ratio
-
91%
-
Price per share
-
$712.33
-
Number of holders
-
1,299
-
Value change
-
-$479,615,848
-
Number of buys
-
550
-
Number of sells
-
702
Institutional Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q4 2024
As of 31 Dec 2024 REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) had 1,299 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 93,286,684 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., FMR LLC, JPMORGAN CHASE & CO, STATE STREET CORP, Capital International Investors, Capital World Investors, GEODE CAPITAL MANAGEMENT, LLC, Dodge & Cox, and PRICE T ROWE ASSOCIATES INC /MD/.
This table shows 1,301 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.